ERS Congress 2013 New Phase III data presented for first time demonstrate: tiotropium* Respimat ® significantly improves lung function and provides sustained bronchodilation in asthma patients who remain symptomatic despite ICS† treatment

ERS Congress 2013 New Phase III data presented for first time demonstrate: tiotropium* Respimat ® significantly improves lung function and provides sustained bronchodilation in asthma patients who remain symptomatic despite ICS† treatment
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news

Related Links:

Authors: Fu Z, Xu Y, Cai C Abstract Objective: To assess the efficacy and safety of omalizumab in children with moderate-to-severe asthma.Data Sources: We systematically searched MEDLINE, EMBASE and Cochrane for randomized controlled trials (inception to January 2020).Study Selections: All RCTs which were conducted in childhood and adolescence with asthma and compared the efficacy or safety of omalizumab were adopted.Results: Three studies with four publications including 1380 pediatric patients met our criteria. For children with moderate-to-severe asthma, omalizumab decreased asthma exacerbations rate (OR 0.51, 9...
Source: Journal of Asthma - Category: Respiratory Medicine Tags: J Asthma Source Type: research
Authors: Ma X, Wang L, Liu L, Yang C, Gai Z Abstract During the COVID-19 outbreak, asthma was very rare in China, and there were significant differences from previous clinical perceptions and the data from American, and we analyzed the possible causes. PMID: 32600166 [PubMed - as supplied by publisher]
Source: Journal of Asthma - Category: Respiratory Medicine Tags: J Asthma Source Type: research
Conclusions: Outdoor PM10 and O3 exposure was associated with reduction in FEV1 in atopic asthmatic and non-asthmatic children. PMID: 32597339 [PubMed - as supplied by publisher]
Source: Journal of Asthma - Category: Respiratory Medicine Tags: J Asthma Source Type: research
We examined the impact of different comorbidities, multimorbidity, lung function and other factors have on survival in COPD and ACO patients. We also examined the causes of death to determine how many patients die of other than respiratory diseases. This retrospective study includes 214 patients with an exacerbation of COPD requiring hospitalisation during the year of 2005. The patients were followed up until the end of year 2015. The survival of ACO patients was significantly higher than COPD patients (4.7 vs. 1.7 years, p = 0.001). Poor lung function predicted worse survival in both patient groups, b...
Source: COPD: Journal of Chronic Obstructive Pulmonary Disease - Category: Respiratory Medicine Tags: COPD Source Type: research
Condition:   Stepping Down Asthma Intervention:   Diagnostic Test: Patients with well controlled asthma Sponsor:   Hat Yai Medical Education Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Asthma;   Asthma in Children Interventions:   Behavioral: AQI intervention;   Other: Routine care Sponsors:   University of Pittsburgh;   American Thoracic Society Foundation Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
(Lancaster University) A new study reveals that the common asthma drug salbutamol may offer potential as a treatment for Alzheimer's disease.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
ALLERGY AND ASTHMA PROCEEDINGS, Volume 41, Number 4, 1 July 2020. Loaded on 2020-07-01
Source: Allergy and Asthma Proceedings - Category: Allergy & Immunology Source Type: research
ConclusionsIn a 13-month, fortnightly survey of patients in France, Italy and Spain with a self-reported history of moderate-to-severe, poorly controlled, HDM-induced allergic rhinitis and asthma, we found that a relevant minority of participants regularly reported a severe or very severe impact of their allergy on tiredness, sleep and professional activities (including time off work). The disease burden peaked in autumn and late spring.
Source: Clinical and Translational Allergy - Category: Allergy & Immunology Source Type: research
Source: Journal of Asthma and Allergy - Category: Allergy & Immunology Tags: Journal of Asthma and Allergy Source Type: research
More News: Asthma | Politics | Research | Spiriva | Tiotropium